Confirmed Preliminary Control Announced Transaction verified Healthcaremedical devicesMedtechpain management

SPR Therapeutics acquired by Medtronic

Medtronic agreed to acquire SPR Therapeutics, a medtech brand, on May 20, 2026.

Preliminary: The announcement date, value basis and value notes are not yet independently verified.

Transaction summary

Target
SPR Therapeutics
Acquirer
Medtronic
Seller
-
Announced
2026-05-20(unverified)
Geography
-
Type
Acquisition
Deal type
Control
Stake acquired
-
First added
2026-07-13
Latest update
2026-10-29

Value and multiples

100% enterprise value

Undisclosed

Value not disclosed | USD

Basis: Undisclosed

Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.

EV / revenue

-

Period not stated

Basis: FundComb estimate

EV / EBITDA

-

EBITDA basis not stated

Basis: FundComb estimate

Basis

  • Enterprise value is unavailable.

Source summary

Medtronic announces intent to acquire SPR Therapeutics, Inc., expanding care options for people living with chronic pain - PR Newswire

Confirmed

PR Newswire announcement dated May 20, 2026 states that Medtronic intends to acquire SPR Therapeutics, a chronic pain-focused medical technology company.

Open source

Continue your research

Explore more comps →